PDGFRB and bladder transitional cell carcinoma: Furthermore, PFI analysis showed that PDGFRB is a risk factor for patients with GBMLGG, KIRP, UVM, KIPAN, LGG, KICH, PAAD, MESO, and BLCA (Fig. 5D).